Efficacy of Probiotic ES1 for the Treatment of Non-Celiac Gluten Sensitivity
Clinical trial NCT02810301 · UNKNOWN
Trial details
- NCT number
- NCT02810301
- Sponsor
- Exzell Pharma Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2017-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.